Nonetheless, late-stage HCC patients tended to show higher TCP1, CCT2/3/4/5/6A/7/8 expression levels, while CCT6B expression was lower in the late stage (Supplementary Figure 3). This evidence concerns the gene CCT2 and hepatocellular carcinoma.